IFM Investors’s Bristol-Myers Squibb BMY Stock Holding History

IFM Investors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.3M	Buy	473,184 +47,131	+11%	+$2.71M	0.18%	100
2026 Q1	$25.8M	Buy	426,053 +4,567	+1%	+$266K	0.22%	87
2025 Q4	$22.7M	Buy	421,486 +8,875	+2%	+$427K	0.19%	96
2025 Q3	$18.2M	Sell	412,611 -827	-0.2%	-$38.6K	0.16%	110
2025 Q2	$19.1M	Buy	413,438 +14,918	+4%	+$732K	0.18%	105
2025 Q1	$24.3M	Buy	398,520 +34	+0%	+$1.98K	0.26%	78
2024 Q4	$22.5M	Sell	398,486 -37,363	-9%	-$2.09M	0.23%	81
2024 Q3	$22.6M	Sell	435,849 -5,728	-1%	-$269K	0.22%	88
2024 Q2	$18.3M	Buy	441,577 +914	+0.2%	+$40.9K	0.19%	102
2024 Q1	$23.9M	Sell	440,663 -5,981	-1%	-$305K	0.26%	73
2023 Q4	$22.9M	Sell	446,644 -2,297	-0.5%	-$121K	0.28%	70
2023 Q3	$26.1M	Buy	448,941 +13,470	+3%	+$825K	0.34%	52
2023 Q2	$27.8M	Buy	435,471 +15,445	+4%	+$1.04M	0.36%	47
2023 Q1	$29.1M	Buy	420,026 +10,295	+3%	+$726K	0.44%	42
2022 Q4	$29.5M	Buy	409,731 +30,923	+8%	+$2.33M	0.5%	37
2022 Q3	$26.9M	Buy	378,808 +3,198	+0.9%	+$232K	0.49%	39
2022 Q2	$28.9M	Buy	375,610 +16,978	+5%	+$1.29M	0.51%	40
2022 Q1	$26.2M	Buy	358,632 +55,413	+18%	+$3.72M	0.41%	49
2021 Q4	$18.9M	Sell	303,219 -777	-0.3%	-$45.6K	0.35%	56
2021 Q3	$18M	Buy	303,996 +138	+0%	+$9.09K	0.37%	50
2021 Q2	$20.3M	Buy	303,858 +52,809	+21%	+$3.44M	0.42%	47
2021 Q1	$15.8M	Buy	251,049 +32,032	+15%	+$1.99M	0.42%	50
2020 Q4	$13.6M	Buy	219,017 +30,652	+16%	+$1.88M	0.43%	49
2020 Q3	$11.4M	Buy	188,365 +20,751	+12%	+$1.25M	0.48%	43
2020 Q2	$9.86M	Sell	167,614 -65,762	-28%	-$3.93M	0.51%	41
2020 Q1	$12.7M	Sell	233,376 -7,762	-3%	-$474K	0.57%	34
2019 Q4	$15.5M	Buy	241,138 +64,607	+37%	+$3.7M	0.55%	34
2019 Q3	$8.95M	Buy	176,531 +61,021	+53%	+$2.87M	0.33%	64
2019 Q2	$5.24M	Buy	115,510 +8,478	+8%	+$395K	0.3%	68
2019 Q1	$5.11M	Buy	107,032 +12,737	+14%	+$634K	0.33%	65
2018 Q4	$4.9M	Buy	94,295 +8,139	+9%	+$437K	0.4%	55
2018 Q3	$5.35M	Buy	86,156 +12,296	+17%	+$730K	0.41%	52
2018 Q2	$4.09M	Buy	73,860 +22,871	+45%	+$1.24M	0.39%	56
2018 Q1	$3.23M	Buy	50,989 +4,956	+11%	+$319K	0.46%	46
2017 Q4	$2.82M	Sell	46,033 -313	-0.7%	-$19.6K	0.45%	44
2017 Q3	$2.95M	Buy	46,346 +730	+2%	+$42.6K	0.5%	43
2017 Q2	$2.54M	Buy	45,616 +11,796	+35%	+$642K	0.46%	43
2017 Q1	$1.84M	Buy	33,820 +12,540	+59%	+$688K	0.47%	42
2016 Q4	$1.24M	Buy	+21,280	New	+$1.16M	0.59%	38

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

IFM Investors's BMY Position: Q2 2026 in Review

IFM Investors increased its Bristol-Myers Squibb (BMY) stake by 11% in Q2 2026, buying an estimated $2.71M and bringing the position to 473,184 shares worth $27.3M. The position accounts for 0.18% of the portfolio, ranked #100.

IFM Investors first reported a position in BMY in Q4 2016 and has held it in 39 quarters since. The position peaked at $29.5M in Q4 2022. 740 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

IFM Investors held 473,184 shares of Bristol-Myers Squibb worth $27.3M as of Q2 2026.
IFM Investors bought 47,131 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.71M.
Bristol-Myers Squibb made up 0.18% of IFM Investors's portfolio in Q2 2026, its #100 holding.
IFM Investors first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 39 quarters since.
IFM Investors's Bristol-Myers Squibb position peaked at $29.5M in Q4 2022.
740 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.